Literature DB >> 2850924

A novel series of potent and selective agonists at the opioid kappa-receptor.

G F Costello1, B G Main, J J Barlow, J A Carroll, J S Shaw.   

Abstract

Three novel opioid agonists are described. These compounds were found to bind with high affinity and selectivity to the kappa-opioid receptor. Isolated tissue studies using the field-stimulated mouse vas deferens and guinea-pig ileum preparations confirmed the high agonist potency and naloxone-reversibility of these agents. All three compounds exhibited potent antinociceptive activity in the mouse abdominal constriction model. These compounds should prove useful as tools to investigate kappa-receptor function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850924     DOI: 10.1016/0014-2999(88)90546-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.

Authors:  P J Birch; H Rogers; A G Hayes; N J Hayward; M B Tyers; D I Scopes; A Naylor; D B Judd
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

2.  NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.

Authors:  Casey O'Connor; Kate L White; Nathalie Doncescu; Tatiana Didenko; Bryan L Roth; Georges Czaplicki; Raymond C Stevens; Kurt Wüthrich; Alain Milon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

3.  CI-977, a novel and selective agonist for the kappa-opioid receptor.

Authors:  J C Hunter; G E Leighton; K G Meecham; S J Boyle; D C Horwell; D C Rees; J Hughes
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

4.  ICI 204448: a kappa-opioid agonist with limited access to the CNS.

Authors:  J S Shaw; J A Carroll; P Alcock; B G Main
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

5.  Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.

Authors:  A Barber; G D Bartoszyk; H E Greiner; F Mauler; R D Murray; C A Seyfried; M Simon; R Gottschlich; J Harting; I Lues
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

6.  A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

Authors:  A Barber; G D Bartoszyk; H M Bender; R Gottschlich; H E Greiner; J Harting; F Mauler; K O Minck; R D Murray; M Simon
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  A series of novel, highly potent and selective agonists for the kappa-opioid receptor.

Authors:  A G Hayes; P J Birch; N J Hayward; M J Sheehan; H Rogers; M B Tyers; D B Judd; D I Scopes; A Naylor
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

8.  Computational design of syntheses leading to compound libraries or isotopically labelled targets.

Authors:  Karol Molga; Piotr Dittwald; Bartosz A Grzybowski
Journal:  Chem Sci       Date:  2019-08-16       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.